This is a Validated Antibody Database (VAD) review about rhesus mac.. CXCR4, based on 29 published articles (read how Labome selects the articles), using CXCR4 antibody in all methods. It is aimed to help Labome visitors find the most suited CXCR4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (12G5)
  • immunohistochemistry; human; loading ...; fig 2d
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in immunohistochemistry on human samples (fig 2d). Bone Rep (2020) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CXCR4 antibody (BioLegend, 306506) was used in flow cytometry on human samples (fig s1b). J Exp Med (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 4e
BioLegend CXCR4 antibody (BioLegend, 306506) was used in flow cytometry on human samples (fig 4e). Cancer Res (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig st1
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1c
In order to study the mechanism of internalization of CXCR4 receptor dependent on MIM and small Rab GTPases., BioLegend CXCR4 antibody (biolegend, 306506) was used in flow cytometry on human samples (fig 1c). J Cell Sci (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:100; loading ...; fig s4b
  • immunocytochemistry; human; 1:50; loading ...; fig s3a
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples at 1:100 (fig s4b) and in immunocytochemistry on human samples at 1:50 (fig s3a). Nat Commun (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BioLegend CXCR4 antibody (BD Pharmingen/BioLegend, I2G5) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 306517) was used . Stem Cell Reports (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 2 ug/ml; fig 5b
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples at 2 ug/ml (fig 5b). Nat Commun (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; mouse; fig 4c
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on mouse samples (fig 4c). J Immunol (2016) ncbi
mouse monoclonal (12G5)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend CXCR4 antibody (BIOLegend, 12G5) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 306510) was used . Sci Rep (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend CXCR4 antibody (Biolegend, 306510) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend, 306510) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (12G5)
In order to elucidate the mechanism by which IFN-beta1b suppresses relapsing-remitting multiple sclerosis, BioLegend CXCR4 antibody (Biolegend, 12G5) was used . Clin Exp Immunol (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:200; fig s4
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples at 1:200 (fig s4). Nat Commun (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend Nos, 306505) was used in flow cytometry on human samples . J Vasc Res (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 5
BioLegend CXCR4 antibody (BioLegend, 306506) was used in flow cytometry on human samples (fig 5). Glycobiology (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 3
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples (fig 3). Clin Cancer Res (2015) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 12G5) was used . Blood Cells Mol Dis (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2f
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig 2f). Blood (2014) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 12G5) was used . J Immunol (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend, 306505) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
Articles Reviewed
  1. Zhang Z, Le K, La Placa D, Armstrong B, Miller M, Shively J. CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils. Bone Rep. 2020;12:100237 pubmed publisher
  2. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed publisher
  3. Jung Y, Cackowski F, Yumoto K, Decker A, Wang J, Kim J, et al. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Res. 2018;78:2026-2039 pubmed publisher
  4. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  5. Li L, Baxter S, Gu N, Ji M, Zhan X. Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. J Cell Sci. 2017;130:1475-1485 pubmed publisher
  6. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  7. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  8. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  9. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  10. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  11. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed publisher
  12. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  13. Kamiyama D, Sekine S, Barsi Rhyne B, Hu J, Chen B, Gilbert L, et al. Versatile protein tagging in cells with split fluorescent protein. Nat Commun. 2016;7:11046 pubmed publisher
  14. Jost T, Borga C, Radaelli E, Romagnani A, Perruzza L, Omodho L, et al. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia. J Leukoc Biol. 2016;99:1077-87 pubmed publisher
  15. Levit Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity P, Rajewsky K, et al. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol. 2016;196:2348-60 pubmed publisher
  16. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  17. Ogaki S, Morooka M, Otera K, Kume S. A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells. Sci Rep. 2015;5:17297 pubmed publisher
  18. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  19. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  20. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed publisher
  21. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  22. Anderson E, Mooney D. The Combination of Vascular Endothelial Growth Factor and Stromal Cell-Derived Factor Induces Superior Angiogenic Sprouting by Outgrowth Endothelial Cells. J Vasc Res. 2015;52:62-9 pubmed publisher
  23. Schneider T, Ehrig K, Liewert I, Alban S. Interference with the CXCL12/CXCR4 axis as potential antitumor strategy: superiority of a sulfated galactofucan from the brown alga Saccharina latissima and fucoidan over heparins. Glycobiology. 2015;25:812-24 pubmed publisher
  24. Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clin Cancer Res. 2015;21:2840-50 pubmed publisher
  25. Bettman N, Avivi I, Rosenbaum H, Bisharat L, Katz T. Impaired migration capacity in monocytes derived from patients with Gaucher disease. Blood Cells Mol Dis. 2015;55:180-6 pubmed publisher
  26. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  27. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  28. Herati R, Reuter M, Dolfi D, Mansfield K, Aung H, Badwan O, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol. 2014;193:3528-37 pubmed publisher
  29. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher